Phase 1a initial single dose study of AV-101 in healthy volunters
Phase of Trial: Phase I
Latest Information Update: 22 Jun 2017
At a glance
- Drugs AV 101 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- 22 Jun 2017 Results from this trial published in a VistaGen Therapeutics Media Release.
- 22 Jun 2017 According to a VistaGen Therapeutics media release, results from this study published in the Scandinavian Journal of Pain.
- 21 Dec 2010 New trial record